Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
29th Mar 20217:00 amRNSCompliance with Market Abuse Regulation
26th Mar 202111:36 amRNSNet Asset Value(s)
25th Mar 202112:00 pmRNSNet Asset Value(s)
24th Mar 202112:55 pmRNSNet Asset Value(s)
23rd Mar 202112:00 pmRNSNet Asset Value(s)
22nd Mar 20212:39 pmRNSGearing disclosure
22nd Mar 20211:50 pmRNSNet Asset Value(s)
19th Mar 202111:30 amRNSNet Asset Value(s)
18th Mar 202110:55 amRNSNet Asset Value(s)
17th Mar 202111:16 amRNSNet Asset Value(s)
16th Mar 202111:16 amRNSNet Asset Value(s)
15th Mar 20212:37 pmRNSGearing disclosure
15th Mar 202111:19 amRNSNet Asset Value(s)
12th Mar 202111:53 amRNSNet Asset Value(s)
11th Mar 20215:01 pmRNSPortfolio disclosures
11th Mar 202110:42 amRNSNet Asset Value(s)
10th Mar 202111:23 amRNSNet Asset Value(s)
9th Mar 202112:53 pmRNSNet Asset Value(s)
8th Mar 202112:46 pmRNSGearing disclosure
8th Mar 202112:11 pmRNSNet Asset Value(s)
5th Mar 202112:11 pmRNSNet Asset Value(s)
4th Mar 20212:28 pmRNSMonth End Net Asset Value(s)
4th Mar 202112:02 pmRNSNet Asset Value(s)
4th Mar 20219:01 amRNSHolding(s) in Company
3rd Mar 202112:41 pmRNSNet Asset Value(s)
2nd Mar 20212:48 pmRNSQuarterly disclosure
2nd Mar 202111:47 amRNSNet Asset Value(s)
1st Mar 20211:42 pmRNSGearing disclosure
26th Feb 202112:50 pmRNSNet Asset Value(s)
25th Feb 202111:49 amRNSNet Asset Value(s)
24th Feb 202111:29 amRNSNet Asset Value(s)
24th Feb 20217:00 amRNSEdison issues review on Aberdeen LatinAmer Inc
23rd Feb 202112:13 pmRNSNet Asset Value(s)
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20212:52 pmRNSGearing disclosure
22nd Feb 202112:08 pmRNSNet Asset Value(s)
19th Feb 20213:49 pmRNSNet Asset Value(s)
18th Feb 202111:00 amRNSNet Asset Value(s)
17th Feb 202111:57 amRNSNet Asset Value(s)
16th Feb 202111:27 amRNSNet Asset Value(s)
15th Feb 202112:31 pmRNSGearing Disclosures
15th Feb 202111:23 amRNSNet Asset Value(s)
12th Feb 202111:39 amRNSNet Asset Value(s)
11th Feb 20214:18 pmRNSPortfolio disclosure
10th Feb 202110:46 amRNSNet Asset Value(s)
9th Feb 202111:01 amRNSNet Asset Value(s)
8th Feb 202112:52 pmRNSGearing disclosure
8th Feb 202111:20 amRNSNet Asset Value(s)
5th Feb 202111:34 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.